Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4257)
All Articles published online
|
Jul 28, 2010 (publication date) through Feb 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maletzki C, Gock M, Klier U, Klar E, Linnebacher M. Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol 2010; 16(28): 3546-3552 [PMID: 20653063 DOI: 10.3748/wjg.v16.i28.3546] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i28/3546.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Jingran Ji, Woo Ram Park, Soojeong Cho, Yihe Yang, Weiguo Li, Kathleen Harris, Xiaoke Huang, Shangzhi Gu, Dong-Hyun Kim, Zhuoli Zhang, Andrew C. Larson. Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging–Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models. Journal of Vascular and Interventional Radiology 2019; 30(7): 1106 doi: 10.1016/j.jvir.2018.11.002
|
| 3 |
Guoying Ni, Tianfang Wang, Lin Yang, Yuejian Wang, Xiaosong Liu, Ming Q. Wei. Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management. Human Vaccines & Immunotherapeutics 2016; 12(3): 599 doi: 10.1080/21645515.2015.1089008
|
| 4 |
Ulrike Klier, Claudia Maletzki, Bernd Kreikemeyer, Ernst Klar, Michael Linnebacher. Combining bacterial-immunotherapy with therapeutic antibodies: A novel therapeutic concept. Vaccine 2012; 30(17): 2786 doi: 10.1016/j.vaccine.2012.01.071
|
| 5 |
Frank T. Wen, Ronald A. Thisted, Donald A. Rowley, Hans Schreiber. A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth. OncoImmunology 2012; 1(2): 172 doi: 10.4161/onci.1.2.18311
|
| 6 |
Atieh Yaghoubi, Kiarash Ghazvini, Majid Khazaei, Seyed Mahdi Hasanian, Amir Avan, Saman Soleimanpour. The use of Clostridium in cancer therapy: a promising way. Reviews and Research in Medical Microbiology 2022; 33(2): 121 doi: 10.1097/MRM.0000000000000281
|
| 7 |
Rosa Behboodi, Arman Saadati Partan, Sepideh Meidaninikjeh, Yasamin Morvarid, Haniyeh Sadat Hosseininia, Maryam Sayhinouri, Armaghan Shirinsokhan, Sahar Javadi, Amin Ebrahimi Sadrabadi, Arsalan Jalili. Clostridium Bacteria: The Team of Microscopic Oncologists. Iranian Journal of Blood and Cancer 2023; 15(4): 178 doi: 10.61186/ijbc.15.4.178
|
| 8 |
Shuping Li, Hua Yue, Shuang Wang, Xin Li, Xiaojun Wang, Peilin Guo, Guanghui Ma, Wei Wei. Advances of bacteria-based delivery systems for modulating tumor microenvironment. Advanced Drug Delivery Reviews 2022; 188: 114444 doi: 10.1016/j.addr.2022.114444
|
| 9 |
Van Anh Thi Nguyen, Hong Anh Huynh, Tong Van Hoang, Ngoc Thi Ninh, An Thi Hong Pham, Hoa Anh Nguyen, Tuan-Nghia Phan, Simon M. Cutting. KilledBacillus subtilisspores expressing streptavidin: a novel carrier of drugs to target cancer cells. Journal of Drug Targeting 2013; 21(6): 528 doi: 10.3109/1061186X.2013.778262
|
| 10 |
Amy E. DeClue, Sandra M. Axiak-Bechtel, Yan Zhang, Saurabh Saha, Linping Zhang, David D. Tung, Jeffrey N. Bryan. Identification of immunologic and clinical characteristics that predict inflammatory response to C. Novyi-NT bacteriolytic immunotherapy. BMC Veterinary Research 2018; 14(1) doi: 10.1186/s12917-018-1424-1
|
| 11 |
Guoying Ni, Yong Wang, David Good, Jianwei Yuan, Xuan Pan, Jou Wei, Xiaosong Liu, Ming Q. Wei. The Dosage of the Derivative ofClostridium Ghonii(DCG) Spores Dictates Whether an IFNγ/IL-9 or a Strong IFNγResponse Is Elicited in TC-1 Tumour Bearing Mice. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1395138
|
| 12 |
Alexandra M. Mowday, Jella M. van de Laak, Zhe Fu, Kimiora L. Henare, Ludwig Dubois, Philippe Lambin, Jan Theys, Adam V. Patterson. Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?. Critical Reviews in Microbiology 2024; 50(6): 955 doi: 10.1080/1040841X.2024.2311653
|
| 13 |
Sun-Young Chang, Yeon-Jeong Kim, Hyun-Jeong Ko. Potential therapeutic anti-tumor effect of aSalmonella-based vaccine. Human Vaccines & Immunotherapeutics 2013; 9(8): 1654 doi: 10.4161/hv.24917
|
| 14 |
Saskia Stier, Claudia Maletzki, Ulrike Klier, Michael Linnebacher. Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/271246
|
| 15 |
Verena Staedtke, Nicholas J. Roberts, Ren-Yuan Bai, Shibin Zhou. Clostridium novyi-NT in cancer therapy. Genes & Diseases 2016; 3(2): 144 doi: 10.1016/j.gendis.2016.01.003
|
| 16 |
Piyush Baindara, Suresh Korpole, Vishakha Grover. Bacteriocins: perspective for the development of novel anticancer drugs. Applied Microbiology and Biotechnology 2018; 102(24): 10393 doi: 10.1007/s00253-018-9420-8
|
| 17 |
Sergio Rius-Rocabert, Francisco Llinares Pinel, Maria Jose Pozuelo, Antonia García, Estanislao Nistal-Villan. Oncolytic bacteria: past, present and future. FEMS Microbiology Letters 2019; 366(12) doi: 10.1093/femsle/fnz136
|
| 18 |
Linfeng Zheng, Zhuoli Zhang, Khashayarsha Khazaie, Saurabh Saha, Robert J. Lewandowski, Guixiang Zhang, Andrew C. Larson, Bing Xu. MRI-Monitored Intra-Tumoral Injection of Iron-Oxide Labeled Clostridium novyi-NT Anaerobes in Pancreatic Carcinoma Mouse Model. PLoS ONE 2014; 9(12): e116204 doi: 10.1371/journal.pone.0116204
|
| 19 |
Li Wang, Qing Wang, Xiaochao Tian, Xinli Shi. Learning from Clostridium novyi-NT. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 1): S1 doi: 10.4103/0973-1482.204841
|
| 20 |
Michael Linnebacher, Claudia Maletzki, Ulrike Klier, Ernst Klar. Bacterial immunotherapy of gastrointestinal tumors. Langenbeck's Archives of Surgery 2012; 397(4): 557 doi: 10.1007/s00423-011-0892-6
|
| 21 |
Xin Zhang, Yang Zhang, Ning Wang, Yetong Shen, Qing Chen, Lu Han, Bo Hu. Photothermal Nanoheaters-Modified Spores for Safe and Controllable Antitumor Therapy. International Journal of Nanomedicine 2022; : 6399 doi: 10.2147/IJN.S385269
|